"Cardiomyopathies - From Basic Research to Clinical Management" ed. by Josef Veselka

This book provides a comprehensive, state-of-the-art review of the current knowledge of cardiomyopathies. Instead of following the classic interdisciplinary division, the entire cardiovascular system is presented as a functional unity, and the contributors explore pathophysiological mechanisms from different perspectives, including genetics, molecular biology, electrophysiology, invasive and non-invasive cardiology, imaging methods and surgery. In order to provide a balanced medical view, this book was edited by a clinical cardiologist.

Contents
Part 1 Classification, Evaluation and Management of Cardiomyopathies
1 Classification and Definitions of Cardiomyopathies
2 Management of Hypertrophic Obstructive Cardiomyopathy with a Focus on Alcohol Septal Ablation
3 Hypertrophic Cardiomyopathy in Infants and Children
4 Quality of Life in Dilated Cardiomyopathy with Refractory Chronic Heart Failure Undergoing Devices Implantation
5 Periparturn Cardiomyopathy: A Systematic Review
6 Cardiomyopathy Detection from Electrocardiogram Features
7 Prevention of Sudden Cardiac Death in Patients with Cardiomyopathy
3 Bio marker for Cardiomyopathy-B-Type Natriuretic Peptide
Part 2 Pathophysiology and Genetics of Cardiomyopathies
9 Heart Muscle and Apoptosis
10 Cardiac Myocytes and Mechanosensation
11 Dobuta mine-induced Mechanical A Iter nans
12 MicroRNAs Telltale Effects on Signaling Networks in Cardiomyopathy
13 Intercellular Connections in the Heart: The Intercalated Disc
14 Familial Hypertrophic Cardiomyopathy-Related Troponin Mutations and Sudden Cardiac Death
15 Consequences of Mutations in Genes Encoding Cardiac Troponin C, T and I - Molecular Insights
16 Cardiomyopathies Associated with Myofibrillar Myopathies
17 Functional Consequences of Mutations in the Myosin Regulatory Light Chain Associated with Hypertrophic Cardiomyopathy
18 Role of Genetic Factors in Dilated Cardiomyopathy
Part 3 Cardiomyopathies and Imaging Methods
19 Role of Advanced Cardiac Magnetic Resonance Imaging in Atypical Cardiomyopathies such as Stress-Induced Cardiomyopathie and Left-Ventricular Non-Compaction Cardiomyopathy
20 The Use of Contrast-Enhancement Cardiovascular Magnetic Resonance Imaging in Cardiomyopathies
Part 4 Metabolic and Drug-Induced Cardiomyopathies
21 The Evolving Face of Heart Failure Associated with Elevated Cardio-Metabolie Risk Factors
22 Diabetic Cardiomyopathy: Cardiac Changes. Pathophvsiological Mechanisms. Biologic Markers, and the Available Therapeutic Armamentarium
23 Insulin Resistance and Cardiomyopathy
24 Taurine Depletion-Related Cardiomyopathy in Animals
25 Thyrotoxic Cardiomyopathy
26 Drug-Induced Cardiomyopathies
27 Anthracycline Cardiotoxicity
28 Cardiotonic Steroids and Cardiac Fibrosis
Part 5 Takotsubo Cardiomyopathy
29 Stress-Induced Cardiomyopathy: Clinical Observations
30 Takotsubo Cardiomyopathy
31 Pathology of Takotsubo (Ampulla) Cardiomyopathy
32 Torsades de Pointes in Takotsubo Cardiomyopathy with QT Prolongation
33 Torsades de Pointes Associated with Takotsubo Cardiomyopathy: Is It Preventable?
Part 6 Chagas Heart Disease
34 Chagas Heart Disease
35 Chagasic Cardiomyopathy